THIAZOL-5-YLMETHYL N-((1S,2S,4S)-1-BENZYL-2-HYDROXY-4-(((2S)-2-((HYDROXY-((2-ISOPROPYLTHIAZOL-4-YL)METHYL)CARBAMOYL)AMINO)-3-METHYL-BUTANOYL)AMINO)-5-PHENYL-PENTYL)CARBAMATE
UNII 534ZWA0OMR
Substance Identification & Data
This profile provides standardized clinical and technical data for Thiazol-5-ylmethyl N-((1s,2s,4s)-1-benzyl-2-hydroxy-4-(((2s)-2-((hydroxy-((2-isopropylthiazol-4-yl)methyl)carbamoyl)amino)-3-methyl-butanoyl)amino)-5-phenyl-pentyl)carbamate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 534ZWA0OMR.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 190649-37-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C36H46N6O6S2 VRECTSFAJINQSP-QJANCWQKSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Thiazol-5-ylmethyl N-((1s,2s,4s)-1-benzyl-2-hydroxy-4-(((2s)-2-((hydroxy-((2-isopropylthiazol-4-yl)methyl)carbamoyl)amino)-3-methyl-butanoyl)amino)-5-phenyl-pentyl)carbamate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.